Covid-19: Cirkom works safely with automation for Biotech and Pharma

Covid-19: Cirkom works safely with automation for Biotech and Pharma

The Corona virus outbreak affects us all. At Cirkom, our everyday life is also changing as we continue our projects and tasks with automation for the Biotech and Pharma industry. We are still experiencing high demand and are therefore working – almost – as usual.

“We are following the development closely and will of course comply with the authorities’ announcements. That’s why we’ll be working from home in the near future. Fortunately, we have a lot of practice holding meetings online, where we can coordinate and talk to each other, and where we can also have a dialog with our customers,” says Martin Næstrup Madsen, Partner and CEO at Cirkom A/S.

“At this point in time, we still have many ongoing projects to complete. Our customers still need our automation solutions and we continue to operate in the best possible way. It may be necessary to meet with our customers to drop off different parts, but we make sure we only meet one-on-one. With good spacing and hygiene.

As always, customers and partners can contact us by phone and email. We make the best of the special circumstances, and then we just look forward to getting back to the office so we can laugh at each other’s jokes again,” says Martin Næstrup Madsen.

Scroll to Top